# NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement

> **NCT01408472** · PHASE1 · COMPLETED · sponsor: **Jeffrey L Goldberg** · enrollment: 11 (actual)

## Conditions studied

- Glaucoma, Primary Open Angle

## Interventions

- **DRUG:** NT-501 CNTF Implant

## Key facts

- **NCT ID:** NCT01408472
- **Lead sponsor:** Jeffrey L Goldberg
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-04
- **Primary completion:** 2013-12
- **Final completion:** 2014-10
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2016-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01408472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01408472, "NT-501 CNTF Implant for Glaucoma: Safety, Neuroprotection and Neuroenhancement". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01408472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*